Ontology highlight
ABSTRACT: Background
Nonalcoholic steatohepatitis (NASH) is a common cause of chronic liver disease. There is a major need to understand the efficacy of different pharmacological agents for the treatment of NASH.Aim
To assess the relative rank-order of different pharmacological interventions in fibrosis improvement and NASH resolution.Methods
A comprehensive search of several databases was conducted by an experienced librarian. We included randomised controlled-trials (RCTs) comparing pharmacological interventions in patients with biopsy-proven NASH. The primary outcome was ≥1 stage improvement in fibrosis. The secondary outcome was NASH resolution.Results
A total of 26 RCTs with 23 interventions met the eligibility criteria. Lanifibranor and obeticholic acid had the
SUBMITTER: Majzoub AM
PROVIDER: S-EPMC8711247 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature